K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Hartmut Döhner
also known as Döhner Hartmut, Döhner, Hartmut, H Dhner
Universität Ulm · University Hospital Ulm · Technische Hochschule Ulm · Goethe University Frankfurt
About this author
Works
1,376
Cited by
114,351
h-index
146
i10
614
ORCID ↗
Top papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
·
2016
·
Blood
↗ 5,829
OA
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
·
2016
·
New England Journal of Medicine
↗ 4,312
OA
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Döhner, Elihu H. Estey, Sergio Amadori, et al.
·
2009
·
Blood
↗ 3,388
OA
Acute Myeloid Leukemia
Hartmut Döhner, Daniel J. Weisdorf, Clara D. Bloomfield
·
2015
·
New England Journal of Medicine
↗ 3,340
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, et al.
·
2000
·
New England Journal of Medicine
↗ 3,290
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
Michael Hallek, Bruce D. Cheson, Daniel Catovsky, et al.
·
2008
·
Blood
↗ 3,186
OA
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner, Andrew H. Wei, Frederick R. Appelbaum, et al.
·
2022
·
Blood
↗ 2,869
OA
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, et al.
·
2020
·
New England Journal of Medicine
↗ 2,704
OA
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
·
2022
·
Blood
↗ 2,559
OA
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford, et al.
·
2017
·
New England Journal of Medicine
↗ 2,166
OA
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson, et al.
·
2010
·
The Lancet
↗ 1,862
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek, Bruce D. Cheson, Daniel Catovsky, et al.
·
2018
·
Blood
↗ 1,661
OA
Books
Molecular Diagnostics in Hematologic Oncology
2008
·
UNI-MED Verlag AG